Teva Pharmaceuticals
TEVA
TEVA
478 hedge funds and large institutions have $8.05B invested in Teva Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 177 increasing their positions, 131 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 20 → 24 (+4)
7% more funds holding
Funds holding: 445 → 478 (+33)
1.33% less ownership
Funds ownership: 52.23% → 50.9% (-1.3%)
Holders
478
Holding in Top 10
24
Calls
$371M
Puts
$255M
Top Buyers
| 1 | +$233M | |
| 2 | +$74.3M | |
| 3 | +$64.3M | |
| 4 |
PCM
Parsifal Capital Management
Greenwich,
Connecticut
|
+$63.6M |
| 5 |
Neuberger Berman Group
New York
|
+$50.5M |
Top Sellers
| 1 | -$359M | |
| 2 | -$139M | |
| 3 | -$101M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$85.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$81.9M |